In infected mice, LTX‑315 demonstrated efficacy against multidrug-resistant and hypervirulent Klebsiella pneumoniae.
In plain wordsIn mice, LTX‑315 showed activity against drug-resistant and highly virulent Klebsiella pneumoniae.
- Peptide
- LTX-315
- Outcome
- Not applicableIn vivo antibacterial efficacy
- Study
mousen: not reported in source
multidrug-resistant and hypervirulent Klebsiella pneumoniae infection- Outcome group
- Infection and antimicrobial activity · Infection
- Studied dose
- Dose not stated
Source sentences
Finally, the efficacy of LTX-315 in vivo against multidrug-resistant and hypervirulent Klebsiella pneumoniae was demonstrated.
1 context sentence(design, population, supporting numbers)
Finally, the efficacy in vivo of LTX-315 against drug-resistant bacteria was proved through amice infection model.